The global malaria vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The occurrence of malaria in tropical countries has been tough globally, contributing to millions of mortalities over the last ten years. The development of vaccines forms a vital part of adequate interventional control. Recent years have seen considerable research on novel vaccine candidates. Supported by continuous research of malaria life-cycle, a diverse pipeline has been investigated. Understanding the biology of lethal human malaria parasites, Plasmodium falciparum and Plasmodium vivax is key to developing avenues within the market. Generations of pre-erythrocytic vaccines have unlocked new possibilities in the market. This has attracted several investments from biotech agencies. This is a factor that is expected to fuel the market growth during the forecast period. Over the past couple of years, researchers have been able to boom the vaccine-induced efficacy substantially. 

The spate of medical trials has targeted enhancing RTS, S/AS01. Such tendencies were invigorated by the latest trials in sub-Saharan Africa. According to the WHO, RTS,S has been evaluated to be used as a complementary malaria control tool to its preventive, diagnostic, as well as treatment measures. It is the only vaccine that has demonstrated its efficacy in reducing malaria, especially in younger African children. The growing number of routine immunization programs in various countries is boosting the market. Over the past few years, the World Health Organisation (WHO) has made coordinated efforts to promote public health by using the vaccine. The advent of novel adjuvants and cutting-edge vaccine delivery platforms are opening new avenues in the market. Another factor that is boosting the market growth includes the growing range of routine immunization programs in various countries. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: GlaxoSmithKline plc, Sanaria Inc., and Sumaya Biotech, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Malaria Vaccines Market Report by Segment

By Agent Type 

• Plasmodium Falciparum

• Plasmodium Vivax 

• Anopheles Species

By Vaccine Type 

• Pre-Erythrocytic Vaccine

• Erythrocytic Vaccine 

• Multi-antigen Vaccine

By Distribution Channel 

• Hospitals

• Clinics 

• Community Centers

Global Malaria Vaccines Market by Region